Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Chronic DIC
jRCTs041180072Completed
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of apixaban in disseminated intravascular coagulation (DIC). Primary endpoint: DIC score change over time. Started May 2017; status: completed.
02
Drugs
apixaban
03
Conditions
disseminated intravascular coagulation (DIC)
Beyond the preview
Go deeper on jRCTs041180072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180072.